Newsroom

Novel vaccine provides protection in poultry flocks against the challenges from MD, ILT and IBD in a single injection RAHWAY, N.J., Feb. 2, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that INNOVAX®-ILT-IBD […]

Read more

RAHWAY, N.J., Jan. 30, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced new ALLFLEX® CleanVax™ nozzles and shields for clean, fast and convenient administration of intranasal vaccines to cattle. The CleanVax intranasal vaccination […]

Read more

Rahway, NJ, January  24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities […]

Read more

More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon. RAHWAY, N.J., Jan. 15, 2024 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today […]

Read more

Study published in Parasites & Vectors demonstrates BRAVECTO® Chews for Dogs has rapid and persistent activity against newly acquired ticks. RAHWAY, N.J., January 10, 2024 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication […]

Read more

Gilvetmab Is Available to Veterinary Specialists Practicing Oncology to Treat Dogs with Mast Cell Tumors and Melanoma Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that its caninized monoclonal antibody gilvetmab (gil-VET-mab) is now available […]

Read more